BECN1 and neoplasm: A low cellular concentration of BECLIN 1 is often associated with the occurrence of cancers [101,102], while the overexpression of BECLIN 1 in certain cancers is correlated with a more aggressive clinical behavior and prolonged survival of a subset of tumor cells, most likely by promoting autophagy and thereby preventing apoptosis [103,104].